Stay updated on SCT: Lisdexamfetamine Trial for ADHD & SCT
Sign up to get notified when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.

Latest updates to the SCT: Lisdexamfetamine Trial for ADHD & SCT page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov study page remains an error page, with the footer revision changing from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check15 days agoChange DetectedThe footer identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record view with an access-denied message. This suggests a temporary access issue or server-side configuration that blocks viewing the content.SummaryDifference0.5%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error replacing the usual study record details, with a minimal header and navigation visible. This blocks access to the study's information and related sections on that page.SummaryDifference17%

Stay in the know with updates to SCT: Lisdexamfetamine Trial for ADHD & SCT
Enter your email address, and we'll notify you when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.